SURGICAL ONCOLOGY:  Why biopsying metastatic breast cancer should be routine

Anand Sharma; Tim Crook; Alastair Thompson; Carlo Palmieri

doi:10.1038/nrclinonc.2009.222

SURGICAL ONCOLOGY: Why biopsying metastatic breast cancer should be routine

Anand Sharma, Tim Crook, Alastair Thompson, Carlo Palmieri

Research output: Contribution to journal › Editorial › peer-review

14 Citations (Scopus)

Abstract

The true burden of metastatic breast cancer worldwide is unknown, although there are approximately 411,000 breast cancer deaths per year worldwide. As the current median survival of newly diagnosed patients with metastatic disease is 20 months, the number of patients alive and living with advanced disease is substantial.

Original language	English
Pages (from-to)	71-74
Number of pages	4
Journal	Nature Reviews Clinical Oncology
Volume	7
Issue number	2
DOIs	https://doi.org/10.1038/nrclinonc.2009.222
Publication status	Published - Feb 2010

Keywords

RECEPTOR
ESTROGEN
THERAPY

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/nrclinonc.2009.222

Cite this

@article{0886ac2865864888bf0a8c2d6e7b7725,

title = "SURGICAL ONCOLOGY: Why biopsying metastatic breast cancer should be routine",

abstract = "The true burden of metastatic breast cancer worldwide is unknown, although there are approximately 411,000 breast cancer deaths per year worldwide. As the current median survival of newly diagnosed patients with metastatic disease is 20 months, the number of patients alive and living with advanced disease is substantial.",

keywords = "RECEPTOR, ESTROGEN, THERAPY",

author = "Anand Sharma and Tim Crook and Alastair Thompson and Carlo Palmieri",

year = "2010",

month = feb,

doi = "10.1038/nrclinonc.2009.222",

language = "English",

volume = "7",

pages = "71--74",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - SURGICAL ONCOLOGY

T2 - Why biopsying metastatic breast cancer should be routine

AU - Sharma, Anand

AU - Crook, Tim

AU - Thompson, Alastair

AU - Palmieri, Carlo

PY - 2010/2

Y1 - 2010/2

N2 - The true burden of metastatic breast cancer worldwide is unknown, although there are approximately 411,000 breast cancer deaths per year worldwide. As the current median survival of newly diagnosed patients with metastatic disease is 20 months, the number of patients alive and living with advanced disease is substantial.

AB - The true burden of metastatic breast cancer worldwide is unknown, although there are approximately 411,000 breast cancer deaths per year worldwide. As the current median survival of newly diagnosed patients with metastatic disease is 20 months, the number of patients alive and living with advanced disease is substantial.

KW - RECEPTOR

KW - ESTROGEN

KW - THERAPY

U2 - 10.1038/nrclinonc.2009.222

DO - 10.1038/nrclinonc.2009.222

M3 - Editorial

C2 - 20118974

SN - 1759-4774

VL - 7

SP - 71

EP - 74

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

IS - 2

ER -